ES377725A1 - Un procedimiento para preparar una tableta adecuada para administracion oral. - Google Patents

Un procedimiento para preparar una tableta adecuada para administracion oral.

Info

Publication number
ES377725A1
ES377725A1 ES377725A ES377725A ES377725A1 ES 377725 A1 ES377725 A1 ES 377725A1 ES 377725 A ES377725 A ES 377725A ES 377725 A ES377725 A ES 377725A ES 377725 A1 ES377725 A1 ES 377725A1
Authority
ES
Spain
Prior art keywords
water soluble
pharmaceutical compositions
acidic compound
translation
combining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES377725A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES377725A1 publication Critical patent/ES377725A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
ES377725A 1969-03-20 1970-03-20 Un procedimiento para preparar una tableta adecuada para administracion oral. Expired ES377725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES377725A1 true ES377725A1 (es) 1972-10-16

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
ES377725A Expired ES377725A1 (es) 1969-03-20 1970-03-20 Un procedimiento para preparar una tableta adecuada para administracion oral.

Country Status (10)

Country Link
BE (1) BE747656A (OSRAM)
DE (1) DE2013039A1 (OSRAM)
DK (1) DK128674B (OSRAM)
ES (1) ES377725A1 (OSRAM)
FI (1) FI51653C (OSRAM)
FR (1) FR2035118B1 (OSRAM)
GB (1) GB1291281A (OSRAM)
IL (1) IL34089A (OSRAM)
NL (1) NL143419B (OSRAM)
SE (1) SE379284B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (OSRAM) * 1970-03-27 1975-08-22 Sankyo Co
US3940483A (en) 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
EP0012495B1 (en) * 1978-12-08 1983-06-22 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
BE747656A (fr) 1970-09-21
FR2035118B1 (OSRAM) 1974-08-30
DE2013039A1 (de) 1970-09-24
NL7004004A (OSRAM) 1970-09-22
GB1291281A (en) 1972-10-04
FI51653C (fi) 1977-03-10
IL34089A (en) 1974-05-16
NL143419B (nl) 1974-10-15
IL34089A0 (en) 1970-05-21
SE379284B (OSRAM) 1975-10-06
DK128674B (da) 1974-06-17
FR2035118A1 (OSRAM) 1970-12-18
FI51653B (OSRAM) 1976-11-30

Similar Documents

Publication Publication Date Title
CH546779A (fr) Procede de preparation de sels pharmaceutiquement acceptables.
ES369624A1 (es) Procedimiento para la produccion de derivados de alcanola- mina.
ES377725A1 (es) Un procedimiento para preparar una tableta adecuada para administracion oral.
IL35840A0 (en) Substituted naphthyl alkyl amines and their salts,their preparation and pharmaceutical compositions containing them
ES329052A1 (es) Metodo de produccion de preparaciones farmaceuticas.
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES410825A1 (es) Procedimiento para la preparacion de derivados de quino- leina.
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
IL36447A0 (en) Aryloxy-and arylthioalkanoic acids and salts and functional derivatives thereof,their production and pharmaceutical compositions containing them
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
NL149793B (nl) Werkwijze ter bereiding van antiparasitair werkzame 5-nitroimidazoolderivaten, werkwijze ter bereiding van farmaceutische preparaten, diervoeders of diervoedertoevoegsels, alsmede de aldus verkregen gevormde voortbrengselen.
ES401228A1 (es) Procedimiento de obtencion de sales complejas de cisteina yde cinc.
ES333664A1 (es) Un procedimiento para la preparacion de agentes antibacterianos.
ES294897A1 (es) Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
NL164552C (nl) Werkwijze ter bereiding van een farmaceutisch prepa- raat; gevormd farmaceutisch preparaat; werkwijze ter bereiding van geneeskrachtige verbindingen.
IL37586A0 (en) Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same
ES377723A1 (es) Un procedimiento para preparar una tableta farmaceutica.
GB1125349A (en) Soluble salts of ellagic acid
IL30488A (en) Pharmaceutical compositions comprising as an active ingredient p-benzoylphenylacetic acid,o-benzoylphenylacetic acid or salts thereof
ES394364A1 (es) Un procedimiento para la preparacion de sales cristalinas de clorhidrato de kanamicina.
IL31294A (en) (hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them
NL173241C (nl) Farmaceutisch preparaat in capsulevorm dat dantroleen bevat.
ES375563A1 (es) Procedimiento de fabricacion semisintetica de sales de fla-vilio.
ES294928A1 (es) Un procedimiento de preparar una composición líquida y estable de tetraciclina